<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Suggested criteria for full &lt;EM&gt;Haemophilus influenza&lt;/EM&gt; type b and &lt;EM&gt;Streptococcus pneumoniae&lt;/EM&gt; immunization status when considering empiric antibiotics for community-acquired pneumonia in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Suggested criteria for full <em>Haemophilus influenza</em> type b and <em>Streptococcus pneumoniae</em> immunization status when considering empiric antibiotics for community-acquired pneumonia in children</h1>
<div class="graphic"><div class="figure"><div class="ttl">Suggested criteria for full <em>Haemophilus influenza</em> type b and <em>Streptococcus pneumoniae</em> immunization status when considering empiric antibiotics for community-acquired pneumonia in children</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="50%"></colgroup> <tbody> <tr> <td class="subtitle1">Current age*</td> <td class="subtitle1">Criteria for full immunization<sup>¶</sup></td> </tr> <tr> <td class="subtitle2_left" colspan="2"><em>Haemophilus influenzae</em> type b</td> </tr> <tr> <td class="indent1">12 to 15 months</td> <td>≥2 doses of Hib conjugate vaccine, with at least one dose at ≥12 months of age</td> </tr> <tr> <td class="indent1" rowspan="2">15 months to 5 years</td> <td>≥2 doses of Hib conjugate vaccine, with at least one dose at ≥12 months of age, <strong>or</strong></td> </tr> <tr> <td>≥1 dose of Hib conjugate vaccine at ≥15 months of age</td> </tr> <tr class="divider_bottom"> <td class="indent1">≥5 years, not high risk<sup>Δ</sup></td> <td>Hib immunization not necessary</td> </tr> <tr> <td class="subtitle2_left" colspan="2"><em>Streptococcus pneumoniae</em></td> </tr> <tr> <td class="indent1" rowspan="2">12 to 24 months</td> <td>≥3 doses of PCV at &lt;16 months, with ≥1 dose at ≥12 months, <strong>or</strong></td> </tr> <tr> <td>2 doses of PCV, both at ≥12 months</td> </tr> <tr> <td class="indent1" rowspan="3">24 months through 5 years</td> <td>≥3 doses of PCV at &lt;16 months, with ≥1 dose at ≥12 months, <strong>or</strong></td> </tr> <tr> <td>2 doses of PCV, both at ≥12 months, <strong>or</strong></td> </tr> <tr> <td>≥1 dose of PCV at ≥24 months</td> </tr> <tr> <td class="indent1">&gt;5 years, not high risk<sup>◊</sup></td> <td>PCV immunization not necessary</td> </tr> </tbody></table></div><div class="graphic_footnotes">Hib: <em>H. influenzae</em> type b; PCV: pneumococcal conjugate vaccine.<br/>* Children younger than 12 months are incompletely immunized against Hib and <em>S. pneumoniae</em>.<br/>¶ Immunizations must be completed at least two weeks before pneumonia diagnosis.<br/>Δ Children at high risk for invasive Hib disease include chemotherapy recipients and those with anatomic or functional asplenia (including sickle cell disease), HIV infection, immunoglobulin deficiency, or early component complement deficiency. Please refer to the UpToDate topic on prevention of <em>H. influenzae</em> infection for a discussion of full Hib immunization in children at high risk for invasive Hib disease.<br/><font class="lozenge">◊</font> Children at high risk for invasive <em>S. pneumoniae</em> disease include those with chronic heart disease (particularly cyanotic congenital heart disease and cardiac failure); chronic lung disease (including asthma if treated with high-dose oral corticosteroid therapy); diabetes mellitus; cerebrospinal fluid leak; cochlear implant; sickle cell disease and other hemoglobinopathies; anatomic or functional asplenia; HIV infection; chronic renal failure; nephrotic syndrome; diseases associated with treatment with immunosuppressive drugs or radiation therapy, including malignant neoplasms, leukemias, lymphomas, and Hodgkin disease; solid organ transplantation; or congenital immunodeficiency. Please refer to the UpToDate topics on PCVs and pneumococcal polysaccharide vaccines for a discussion of full <em>S. pneumoniae</em> immunization in children at high risk for invasive <em>S. pneumoniae</em> disease.</div><div id="graphicVersion">Graphic 95852 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
